United States 116th Congress Status: In Committee 1 R cosponsors

HR 1362 — Medical Innovation Never Stops Act of 2019

Last action — Referred to the Subcommittee on Health.

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 116th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.

Summary

Medical Innovation Never Stops Act of 2019 This bill requires the Food and Drug Administration (FDA) to accept and review new medical device applications and associated user fees during a lapse in appropriations. Under current law, the FDA is prohibited from accepting new user fees and reviewing medical device submissions during an appropriations lapse.

Bill Text

Action History

  1. Introduced in House

  2. Introduced in House

  3. Referred to the House Committee on Energy and Commerce.

  4. Referred to the Subcommittee on Health.

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 546 not signed on

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (546)

546 members have not signed on to this bill.

Show all 546 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HR 1362 do?
Medical Innovation Never Stops Act of 2019 This bill requires the Food and Drug Administration (FDA) to accept and review new medical device applications and associated user fees during a lapse in appropriations. Under current law, the FDA is prohibited from accepting new user fees and reviewing medical device submissions during an appropriations lapse.
Who sponsors HR 1362?
HR 1362 is sponsored by Emmer, Tom (Republican).
What is the current status of HR 1362?
This bill died with 116th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track HR 1362?
Track HR 1362 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HR 1362

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HR 1362

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →